Hyoscine-N-Butyl Bromide Market (Updated Version Available)

The report offers detailed coverage of Hyoscine-N-Butyl Bromide industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Hyoscine-N-Butyl Bromide by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Hyoscine-N-Butyl Bromideis obtained from a species of the plant genus Duboisia. It is mainly classified as an antispasmodic, which means that it is a drug used to suppress of muscle spasms, or involuntary contractions.

It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms.

Hyoscine-N-Butyl Bromideis obtained from a species of the plant genus Duboisia. It is mainly classified as an antispasmodic, which means that it is a drug used to suppress of muscle spasms, or involuntary contractions.
The production of Hyoscine-N-Butyl Bromideis increased from 6.3 MT in 2012 to 6.9 MT in 2016, at a CARG 2.54%. The manufacturers are Boehringer-Ingelheim, Linnea, Alchem International and Alkaloids.
Boehringer-Ingelheim is the world leader with 77.62% of market share in 2016. Boehringer-Ingelheim produces both Hyoscine-N-Butyl Bromideis API and Buscopan. They mainly sale Buscopan in market and the revenue of Buscopan is 236 EUR million and the revenue of Hyoscine-N-Butyl Bromideis API is 30.2 million USD in 2016.

The report forecast global Hyoscine-N-Butyl Bromide market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.

First, this report covers the present status and the future prospects of the global Hyoscine-N-Butyl Bromide market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

Key Companies
Boehringer-Ingelheim
Linnea, Alchem International
Alkaloids

At the same time, we classify Hyoscine-N-Butyl Bromide according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Market Segment as follows:
Market by Order Type
Boehringer-Ingelheim
Linnea
Alchem International
Alkaloids
Market by Application
Oral
Injection

By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Hyoscine-N-Butyl Bromide market for the forecast period 2021 - 2025?
• What are the driving forces in the Hyoscine-N-Butyl Bromide market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Hyoscine-N-Butyl Bromide industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?